Ratni, H., Scalco, R. S., & Stephan, A. H. (2021). Risdiplam, the First Approved Small Molecule Splicing Modifier Drug as a Blueprint for Future Transformative Medicines. ACS Med Chem Lett.
Chicago Style CitationRatni, Hasane, Renata S. Scalco, i Alexander H. Stephan. "Risdiplam, the First Approved Small Molecule Splicing Modifier Drug As a Blueprint for Future Transformative Medicines." ACS Med Chem Lett 2021.
Cita MLARatni, Hasane, Renata S. Scalco, i Alexander H. Stephan. "Risdiplam, the First Approved Small Molecule Splicing Modifier Drug As a Blueprint for Future Transformative Medicines." ACS Med Chem Lett 2021.
Atenció: Aquestes cites poden no estar 100% correctes.